Abstract
Tacrolimus is the cornerstone of immunosuppression in kidney transplantation (KT). Time-in-therapeutic range (TTR) and time-to-therapeutic level has been highlighted as a potential method of tacrolimus monitoring. We evaluated the tacrolimus TTR, time-to therapeutic level and adverse outcomes present in the Malaysian population in the 1-year post-KT.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.